NDVTX
Price
$18.07
Change
-$0.08 (-0.44%)
Updated
Sep 11 closing price
Net Assets
2.22B
SSGSX
Price
$51.83
Change
+$0.15 (+0.29%)
Updated
Sep 11 closing price
Net Assets
4.09B
Interact to see
Advertisement

NDVTX vs SSGSX

NDVTX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
NDVTX vs. SSGSX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDVTX is a Hold and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.1B vs. NDVTX (2.22B). NDVTX pays higher dividends than SSGSX: NDVTX (0.87) vs SSGSX (0.52). NDVTX was incepted earlier than SSGSX: NDVTX (15 years) vs SSGSX (27 years). NDVTX (1.23) and SSGSX (1.23) have similar cost to investors . SSGSX is a more actively managed with annual turnover of: 50.00 vs. NDVTX (47.00). NDVTX has a lower initial minimum investment than SSGSX: NDVTX (0) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 8.91 vs. NDVTX (-0.34). SSGSX return over 5 years is better than : -2.55 vs. NDVTX (-7.48).
NDVTXSSGSXNDVTX / SSGSX
Total Expense Ratio1.221.2399%
Annual Report Gross Expense Ratio1.231.23100%
Fund Existence15 years27 years-
Gain YTD8.04815.64151%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets2.22B4.1B54%
Annual Yield % from dividends0.870.52168%
Returns for 1 year-0.348.91-4%
Returns for 3 years10.5812.9682%
Returns for 5 years-7.48-2.55294%
Returns for 10 years45.5435.89127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOLM10.000.33
+3.37%
Amplify Solana 3% Monthly Opt Inc ETF
JPME124.890.94
+0.76%
JPMorgan Divers Ret US Mid Cp Eq ETF
SEPT38.350.25
+0.65%
AllianzIM US Equity Buffer10 Sep ETF
PSTP37.400.18
+0.49%
Innovator Power Buffer Step-Up Stgy ETF
FBT261.85-0.43
-0.16%
First Trust NYSE Arca Biotech ETF